Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT05874219

Mupirocin 2% Ointment Vs Spray Antibiotics on Temporary Hemodialysis Catheter

The Effect of Mupirocin 2% Ointment on the Duration of Stay of Temporary Hemodialysis Catheter Compared to Other Spray Antibiotics

Sponsor: Future University in Egypt

Conditions Hemodialysis Catheter Infection Hemodialysis Complication

Interventions Local antibiotic spray Neomycin sulphate 165,000 IU + Bacitracin zinc 12,500 IU Mupirocin 2% ointment

Updated 4 times since 2023 Last updated: Aug 20, 2023 Started: Apr 10, 2023 Primary completion: May 25, 2023 Completion: May 25, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Hemodialysis Catheter Infection and Hemodialysis Complication and is currently completed. Future University in Egypt leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Sep 2023 — Jul 2024 [monthly]

Completed PHASE2_PHASE3

Status: Recruiting → Completed
Jun 2023 — Sep 2023 [monthly]

Recruiting PHASE2_PHASE3

First recorded

Apr 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Future University in Egypt

Data source: Future University in Egypt

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt